Although drugs such as cholinesterase inhibitors and memantine have shown beneficial effects in individuals with poststroke cognitive impairment, the effects of these drugs are still controversial (O'Sullivan et al., 2023). The gene discussed is BCHE; the disease is Cognitive impairment.